Effects of L-dopa in autism
A study was designed to determine if blood serotonin concentrations could be lowered in autistic children by the administration of L-dopa and, if so, to observe possible clinical or physiological changes. Following a 17-day placebo period, four hospitalized autistic boys (3, 4, 9, and 13 years of age) received L-dopa for 6 months. Results indicated a significant decrease of blood serotonin concentrations in the three youngest patients, a significant increase in platelet counts in the youngest patient, and a similar trend in others. Urinary excretion of 5HIAA decreased significantly in the 4-year-old patient and a similar trend was noted in others. No changes were observed in the clinical course of the disorder, the amount of motility disturbances (hand-flapping), percent of REM sleep time, or in measures of endocrine function (FSH and LH). Possible mechanisms by which L-dopa lowered blood serotonin concentrations, increased platelet counts, and yet failed to produce other changes are discussed.
Unable to display preview. Download preview PDF.
- Boullin, D. J., & O'Brien, R. A. Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-dopa.British Journal of Pharmacology and Chemotherapy, 1970,39, 779–788.Google Scholar
- Kales, A., Ritvo, E. R., Scharf, M. B., Tan, T. L., & Preston, T. Effects of L-dopa on the sleep of autistic children.Psychophysiology, 1971 (in press).Google Scholar
- Korf, J., & Valkenburgh-Sikkema, T. Fluorimetric determination of 5-hydroxy-indoleacetic acid in human urine and cerebrospinal fluid.Clinica Chimica Acta, 1969,26, 301–305.Google Scholar
- Rimland, B.Infantile autism. New York: Appleton-Century-Crofts, 1964.Google Scholar
- Ritvo, E. R., Yuwiler, A., Geller, E., Plotkin, S., & Mason, A. Maturational changes in blood serotonin levels and platelet counts.Biochemical Medicine, 1971 (in press).Google Scholar
- Sawyer, C., & Gorski, R. (Ed.),Steroid hormones and brain function. Forum in Medical Sciences 14, University of California Press. Berkeley: 1971.Google Scholar
- Schott, H. B., & Clark, W. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.Journal of Biochemistry, 1952,196, 449.Google Scholar
- Weigand, R., & Perry, J. Effects of L-dopa, N-methyl N-benzyl-2 propynlamine HCl on DOPA, DOPAmine, norepinephrine, and serotonin levels in mouse brain.Biochemical Pharmacology, 1961,1, 181–186.Google Scholar
- Wing, J.Early infantile autism. Oxford: Pergamon Press, 1966.Google Scholar
- Yuwiler, A., Geller, E., & Eiduson, S. Studies on 5-hydroxytryptophane decarboxylase. I.in vitro inhibition and substrate interactions.Archives of Biochemistry and Biophysics, 1959,80, 162–173.Google Scholar
- Zarcone, V., Kales, A., Scharf, M., Tan, T., Simmons, J., Barchas, J., & Dement, W. The effects of chronic oral ingestion of 5HTP on physiology and blood levels of 5-HT in two schizophrenic children.Psychophysiology, 1970,7, 319.Google Scholar